Literature DB >> 12815480

A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors.

S L Petersen1, L P Ryder, P Björk, H O Madsen, C Heilmann, N Jacobsen, H Sengeløv, L L Vindeløv.   

Abstract

This retrospective study compares the reconstitution of T, B and NK cells in three groups of patients transplanted for haematological malignancies with grafts from their HLA-identical sibling donors. In all, 15 patients received PBSC after a nonmyeloablative conditioning regimen consisting of fludarabine and 200 cGy TBI, 13 patients received PBSC after myeloablative conditioning and 37 patients received BM after myeloablative conditioning. In the nonmyeloablative group, the NK cells normalised after 1 month, the CD8+ T cells normalised after 3 months, the CD4+ T cells reached near normal values after 9 months and the B cell values were reduced until 12 months after transplant. In the two myeloablative groups, recipients of PBSC had a significantly higher number of CD4+ T cells after 4 months (P=0.004) and after 12 months (P=0.001), than recipients of BM. We found no differences in the T cell reconstitution between the two PBSC groups. This was of interest as the recipients of nonmyeloablative conditioning were older (P<0.001) and had a higher occurrence of chronic GVHD (P<0.05) than the recipients of myeloablative conditioning. In contrast, the recipients of nonmyeloablative conditioning had a delayed B cell recovery when compared to the patients who received myeloablative conditioning (P=0.04).

Entities:  

Mesh:

Year:  2003        PMID: 12815480     DOI: 10.1038/sj.bmt.1704084

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  22 in total

1.  Bone marrow transplantation with a reduced-intensity conditioning regimen in a patient with Wegener granulomatosis and therapy-related leukemia.

Authors:  Akane Kunitomi; Takayuki Ishikawa; Kenichirou Tajima; Yoshiteru Konaka; Masato Yagita
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

2.  Immune reconstitution in patients with acquired severe aplastic anemia after haploidentical stem cell transplantation.

Authors:  X-Y Pei; X-Y Zhao; L-P Xu; Y Wang; X-H Zhang; Y-J Chang; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2017-08-14       Impact factor: 5.483

Review 3.  Can we make a better match or mismatch with KIR genotyping?

Authors:  Rohtesh S Mehta; Katayoun Rezvani
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

4.  Adaptive NK cell reconstitution is associated with better clinical outcomes.

Authors:  Frank Cichocki; Emily Taras; Flavia Chiuppesi; John E Wagner; Bruce R Blazar; Claudio Brunstein; Xianghua Luo; Don J Diamond; Sarah Cooley; Daniel J Weisdorf; Jeffrey S Miller
Journal:  JCI Insight       Date:  2019-01-24

Review 5.  How important is NK alloreactivity and KIR in allogeneic transplantation?

Authors:  Brian C Shaffer; Katharine C Hsu
Journal:  Best Pract Res Clin Haematol       Date:  2016-10-20       Impact factor: 3.020

6.  Peripheral blood Th9 cells reconstitution and its relationship with acute graft-versus-host disease after matched-sibling peripheral blood hematopoietic stem cell transplantation.

Authors:  Nannan Pang; Jianli Xu; Jianhua Qu; Xianlin Duan; Hailong Yuan; Gang Chen; Ming Jiang; Jianbing Ding
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 7.  Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection.

Authors:  Rohtesh S Mehta; Katayoun Rezvani
Journal:  Virulence       Date:  2016-07-06       Impact factor: 5.882

Review 8.  Murine models of chronic graft-versus-host disease: insights and unresolved issues.

Authors:  Yu-Waye Chu; Ronald E Gress
Journal:  Biol Blood Marrow Transplant       Date:  2008-02-13       Impact factor: 5.742

Review 9.  Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation.

Authors:  Kirsten M Williams; Ronald E Gress
Journal:  Best Pract Res Clin Haematol       Date:  2008-09       Impact factor: 3.020

10.  A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation.

Authors:  Li Li; Han Chen; David Marin; Yuanxin Xi; Qi Miao; Jiangxing Lv; Pinaki Prosad Banerjee; Hila Shaim; May Daher; Rafet Basar; Nobuhiko Imahashi; Juan Jimenez; Bingqian Hu; Rohtesh S Mehta; Lucila Nassif Kerbauy; Mecit Kaplan; Mayela Mendt; Gonca Ozcan; Elif Gokdemir; Mayra Hernandez Sanabria; Ye Li; Ken Chen; Jing Wang; Luis Muniz-Feliciano; Wei-Li Zhao; Richard E Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood Adv       Date:  2019-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.